November 2011

AZ bolsters VC arm with $100 million, buys into Australian firm

AZ bolsters VC arm with $100 million, buys into Australian firm

Pharma Times, UK

Bristol-Pfizer drug gets FDA priority review

Bristol-Pfizer drug gets FDA priority review

Reuters

Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug Q

Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug

Bloomberg

Onyx Pharmaceuticals said to consider sale: report

Onyx Pharmaceuticals said to consider sale: report

Marketwatch

Pfizer's Xalkori: The Story Can Only Get Better

Pfizer's Xalkori: The Story Can Only Get Better

Seeking Alpha

Facebook apologizes for Merck homepage mix-up

Facebook apologizes for Merck homepage mix-up

Reuters

Pfizer's Tanezumab Research Setback Cannot Stop A Strong Investment

Pfizer's Tanezumab Research Setback Cannot Stop A Strong Investment

Seeking Alpha

Countdown to Generic Lipitor: Atorvastatin By Any Other Name

Countdown to Generic Lipitor: Atorvastatin By Any Other Name

WSJ Online

Developer looks to nanoparticles for smoking cessation vaccine

Developer looks to nanoparticles for smoking cessation vaccine

Fierce Biotech

Supreme Court will hear sales-rep overtime dispute

Supreme Court will hear sales-rep overtime dispute

Fierce Pharma